09/03/2026
New Research Sheds Light on Maternal and Newborn Health Risks in Kenya.
A global research initiative is providing a clearer picture of the health challenges facing mothers and infants in Western Kenya. The Pregnancy Risk, Infant Surveillance, and Measurement Alliance (PRISMA) study, a collaborative effort involving the Kenya Medical Research Institute (KEMRI) and George Washington University, recently shared interim findings aimed at improving maternal and neonatal outcomes.
The study, funded by the Bill & Melinda Gates Foundation, followed more than 2,700 women in Siaya and Kisumu Counties. Researchers tracked participants from early pregnancy—specifically before 20 weeks gestation—through one year after delivery to identify key risk factors for illness and death.
The interim data highlights several significant hurdles for maternal health in the region, approximately 32% of pregnant women in the study suffered from anemia. Other identified conditions include HIV, malaria, helminths (parasitic worms), and syphilis.
Rates of maternal hypertension disorders, including pre-eclampsia and eclampsia, are reportedly on the rise. These conditions are closely linked to dangerous complications such as preterm birth, postpartum haemorrhage (PPH), and early neonatal death.
While antepartum haemorrhage (APH) affected 1.6% of the overall study group, postpartum haemorrhage was more prevalent, affecting 5.0% of women. The study found that breastfeeding initiation within the first hour of birth—a critical step for infant health—is only slightly above 50% across most monitored facilities.
The research Spanned six facilities , including Jaramogi Oginga Odinga Teaching and Referral Hospital (JOOTRH).
The data indicates that there was 5.0% Prevalence on postpartum Hemorrage (PPH) , Gestation hypertension had 6.6% , gestation diabetes scored 2.8% , Pre-eclampsia recorded a prevalence of 2.2%, antepartum Hemorrhage (APH) had a prevenance of 1.6% while chronic hypertension has a prevenance of 1.3% .
The PRISMA team is not just collecting data; they are working with county health officials to provide immediate support. This includes providing ultrasound machines, blood pressure monitors, and equipment to check newborn oxygen levels.
Looking ahead to 2026, the next phase of the study (PRISMA v3) aims to expand its reach. Future efforts will integrate AI-enabled imaging, assess environmental exposures, and validate new tools like a point-of-care blood pressure app to better predict and manage risks for mothers and their babies